ABVC BioPharma, Inc. (ABVC) Tops Q3 EPS by 38c

ABVC BioPharma, Inc. (NASDAQ: ABVC) reported Q3 EPS of ($0.02), $0.38 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $380 thousand versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on ABVC BioPharma, Inc. (ABVC) click here.

You May Also Be Interested In

• Jefferies Downgrades Belimo Holding AG (BEAN:SW) (BLHWF) to Hold
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral